Mumbai Protocol is for one in darkness engaged of tuberculosis research. At a period when clinicians around the world are consumed with rifampicin to an in consideration of believing that no regime against tuberculosis can work outside it, the Mumbai protocol has opened a new street in the practice of medicine. The well-known regimen encompassing of rifampicin, ethambutol, pyrazinamide and isoniazide had ample number of situations. The main challenge in this regimen was doctoring patients accompanying hepato-pathology, as all of these drugs are well hepatotoxic. Even they have shown to cause drug inferred hepatic failure in athletic individuals. The Mumbai protocol contradicts all these. It comprises of Streptomycin, cycloserine, p-amino salicylic acid and ethambutol. A complete pardon of pulmonary tuberculosis was seen utilizing this regime in just one month accompanying improvement in liver function. The objective concerning this study was to label and develop a more efficient and safer drug combination remedy for successful and fast pardon of tuberculosis; that has been capably fulfilled.
Author(s) Details:
Soham Samajpaty,
Department
of General Medicine, International Faculty, Russian National Research Medical
University named after NI Pirogov, Moscow, Russian Federation.
Please see the link here: https://stm.bookpi.org/CODHR-V8/article/view/9027
No comments:
Post a Comment